Jean-Jacques Soghomonian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jean-Jacques Soghomonian has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Nathalie Laprade
Department of Anatomy and Physiology, University Laval, Québec, Canada
6 shared publicationsGene J. Blatt
Program on Neuroscience, Hussman Institute for Autism, Baltimore, MD, 21201
4 shared publicationsLaurent Descarries
Départment de Physiologie, Faculté de Medécine, Université de Montréal, Qué, Canada
4 shared publicationsGuy Doucet
Départements de physiologie et de pathologie, Centre de recherche en sciences neurologiques, Faculté de médecine, Université de Montréal, Montréal, Qué. Canada
3 shared publicationsPascal Salin
Department of Pharmacology, University of Pennsylvania, School of Medicine, 36th Street and Hamilton Walk, Philadelphia, PA 19104–6084 USA
3 shared publicationsAmélie C. Lanoue
Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA 02118, USA
2 shared publications
Latest Publications
- Open Access
- 11 January 2024
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 17, 1329095
The cortico-striatal circuitry in autism-spectrum disorders: a balancing act
The basal ganglia are major targets of cortical inputs and, in turn, modulate cortical function via their projections to the motor and prefrontal cortices. The role of the basal ganglia in motor control and reward is well documented and there is also extensive evidence that they play a key role in social and repetitive behaviors. The basal ganglia influence the activity of the cerebral cortex via two major projections from the striatum to the output nuclei, the globus pallidus internus and the substantia nigra, pars reticulata. This modulation involves a direct projection known as the direct pathway and an indirect projection via the globus pallidus externus and the subthalamic nucleus, known as the indirect pathway. This review discusses the respective contribution of the direct and indirect pathways to social and repetitive behaviors in neurotypical conditions and in autism spectrum disorders.
- 11 January 2024
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 17, 1329095
Open AccessThe cortico-striatal circuitry in autism-spectrum disorders: a balancing act
The basal ganglia are major targets of cortical inputs and, in turn, modulate cortical function via their projections to the motor and prefrontal cortices. The role of the basal ganglia in motor control and reward is well documented and there is also extensive evidence that they play a key role in social and repetitive behaviors. The basal ganglia influence the activity of the cerebral cortex via two major projections from the striatum to the output nuclei, the globus pallidus internus and the substantia nigra, pars reticulata. This modulation involves a direct projection known as the direct pathway and an indirect projection via the globus pallidus externus and the subthalamic nucleus, known as the indirect pathway. This review discusses the respective contribution of the direct and indirect pathways to social and repetitive behaviors in neurotypical conditions and in autism spectrum disorders.
- 21 July 2017
- Published by Wiley in Autism Research
- Vol. 10 (11) , 1751-1775
Basal ganglia and autism – a translational perspective
The basal ganglia are a collection of nuclei below the cortical surface that are involved in both motor and non‐motor functions, including higher order cognition, social interactions, speech, and repetitive behaviors. Motor development milestones that are delayed in autism such as gross motor, fine motor and walking can aid in early diagnosis of autism. Neuropathology and neuroimaging findings in autism cases revealed volumetric changes and altered cell density in select basal ganglia nuclei. Interestingly, in autism, both the basal ganglia and the cerebellum are impacted both in their motor and non‐motor domains and recently, found to be connected via the pons through a short disynaptic pathway. In typically developing individuals, the basal ganglia plays an important role in: eye movement, movement coordination, sensory modulation and processing, eye‐hand coordination, action chaining, and inhibition control. Genetic models have proved to be useful toward understanding cellular and molecular changes at the synaptic level in the basal ganglia that may in part contribute to these autism‐related behaviors. In autism, basal ganglia functions in motor skill acquisition and development are altered, thus disrupting the normal flow of feedback to the cortex. Taken together, there is an abundance of emerging evidence that the basal ganglia likely plays critical roles in maintaining an inhibitory balance between cortical and subcortical structures, critical for normal motor actions and cognitive functions. In autism, this inhibitory balance is disturbed thus impacting key pathways that affect normal cortical network activity. Autism Res 2017, 10: 1751–1775. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.Lay Summary: Habit learning, action selection and performance are modulated by the basal ganglia, a collection of groups of neurons located below the cerebral cortex in the brain. In autism, there is emerging evidence that parts of the basal ganglia are structurally and functionally altered disrupting normal information flow. The basal ganglia through its interconnected circuits with the cerebral cortex and the cerebellum can potentially impact various motor and cognitive functions in the autism brain.
- 21 July 2017
- Published by Wiley in Autism Research
- Vol. 10 (11) , 1751-1775
Basal ganglia and autism – a translational perspective
The basal ganglia are a collection of nuclei below the cortical surface that are involved in both motor and non‐motor functions, including higher order cognition, social interactions, speech, and repetitive behaviors. Motor development milestones that are delayed in autism such as gross motor, fine motor and walking can aid in early diagnosis of autism. Neuropathology and neuroimaging findings in autism cases revealed volumetric changes and altered cell density in select basal ganglia nuclei. Interestingly, in autism, both the basal ganglia and the cerebellum are impacted both in their motor and non‐motor domains and recently, found to be connected via the pons through a short disynaptic pathway. In typically developing individuals, the basal ganglia plays an important role in: eye movement, movement coordination, sensory modulation and processing, eye‐hand coordination, action chaining, and inhibition control. Genetic models have proved to be useful toward understanding cellular and molecular changes at the synaptic level in the basal ganglia that may in part contribute to these autism‐related behaviors. In autism, basal ganglia functions in motor skill acquisition and development are altered, thus disrupting the normal flow of feedback to the cortex. Taken together, there is an abundance of emerging evidence that the basal ganglia likely plays critical roles in maintaining an inhibitory balance between cortical and subcortical structures, critical for normal motor actions and cognitive functions. In autism, this inhibitory balance is disturbed thus impacting key pathways that affect normal cortical network activity. Autism Res 2017, 10: 1751–1775. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.Lay Summary: Habit learning, action selection and performance are modulated by the basal ganglia, a collection of groups of neurons located below the cerebral cortex in the brain. In autism, there is emerging evidence that parts of the basal ganglia are structurally and functionally altered disrupting normal information flow. The basal ganglia through its interconnected circuits with the cerebral cortex and the cerebellum can potentially impact various motor and cognitive functions in the autism brain.
- 14 July 2017
- Published by Wiley in Autism Research
- Vol. 10 (11) , 1787-1796
Decreased parvalbumin mRNA levels in cerebellar Purkinje cells in autism
Recent neuropathology studies in human brains indicate that several areas of the prefrontal cortex have decreased numbers of parvalbumin interneurons or decreased parvalbumin expression in Autism Spectrum disorders (ASD) [Hashemi, Ariza, Rogers, Noctor, & Martinez‐Cerdeno, 2017; Zikopoulos & Barbas, ]. These data suggest that a deficit in parvalbumin may be a key neuropathology of ASD and contribute to altered GABAergic inhibition. However, it is unclear if a deficit in parvalbumin is a phenomenon that occurs in regions other than the cerebral cortex. The cerebellum is a major region where neuropathology was first detected in ASD over three decades ago [Bauman & Kemper, ]. In view of the documented association between parvalbumin‐expressing neurons and autism, the objective of the present study was to determine if parvalbumin gene expression is also altered in Purkinje neurons of the cerebellum. Radioisotopic in situ hybridization histochemistry was used on human tissue sections from control and ASD brains in order to detect and measure parvalbumin mRNA levels at the single cell level in Purkinje cells of Crus II of the lateral cerebellar hemispheres. Results indicate that parvalbumin mRNA levels are significantly lower in Purkinje cells in ASD compared to control brains. This decrease was not influenced by post‐mortem interval or age at death. This result indicates that decreased parvalbumin expression is a more widespread feature of ASD. We discuss how this decrease may be implicated in altered cerebellar output to the cerebral cortex and in key ASD symptoms. Autism Res 2017, 10: 1787–1796. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.Lay Summary: The cerebellum of the brain controls movement and cognition, including memory and language. This study investigated mechanisms of cerebellar function in Autism. Our hypothesis is that parvalbumin, a molecule that controls and coordinate many cellular brain functions, contributes to the excitatory/inhibitory imbalance in Autism. We report that parvalbumin expression is depressed in Purkinje cells of the cerebellum in autism. This finding contributes to elucidate the cellular and molecular underpinings of autism and should provide a direction for future therapies.
- 14 July 2017
- Published by Wiley in Autism Research
- Vol. 10 (11) , 1787-1796
Decreased parvalbumin mRNA levels in cerebellar Purkinje cells in autism
Recent neuropathology studies in human brains indicate that several areas of the prefrontal cortex have decreased numbers of parvalbumin interneurons or decreased parvalbumin expression in Autism Spectrum disorders (ASD) [Hashemi, Ariza, Rogers, Noctor, & Martinez‐Cerdeno, 2017; Zikopoulos & Barbas, ]. These data suggest that a deficit in parvalbumin may be a key neuropathology of ASD and contribute to altered GABAergic inhibition. However, it is unclear if a deficit in parvalbumin is a phenomenon that occurs in regions other than the cerebral cortex. The cerebellum is a major region where neuropathology was first detected in ASD over three decades ago [Bauman & Kemper, ]. In view of the documented association between parvalbumin‐expressing neurons and autism, the objective of the present study was to determine if parvalbumin gene expression is also altered in Purkinje neurons of the cerebellum. Radioisotopic in situ hybridization histochemistry was used on human tissue sections from control and ASD brains in order to detect and measure parvalbumin mRNA levels at the single cell level in Purkinje cells of Crus II of the lateral cerebellar hemispheres. Results indicate that parvalbumin mRNA levels are significantly lower in Purkinje cells in ASD compared to control brains. This decrease was not influenced by post‐mortem interval or age at death. This result indicates that decreased parvalbumin expression is a more widespread feature of ASD. We discuss how this decrease may be implicated in altered cerebellar output to the cerebral cortex and in key ASD symptoms. Autism Res 2017, 10: 1787–1796. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.Lay Summary: The cerebellum of the brain controls movement and cognition, including memory and language. This study investigated mechanisms of cerebellar function in Autism. Our hypothesis is that parvalbumin, a molecule that controls and coordinate many cellular brain functions, contributes to the excitatory/inhibitory imbalance in Autism. We report that parvalbumin expression is depressed in Purkinje cells of the cerebellum in autism. This finding contributes to elucidate the cellular and molecular underpinings of autism and should provide a direction for future therapies.
- 5 November 2016
- Published by Springer Nature
- p. 1-8
Introduction: Overview of the Basal Ganglia and Structure of the Volume
- 5 November 2016
- Published by Springer Nature
- p. 1-8
Introduction: Overview of the Basal Ganglia and Structure of the Volume
- 5 November 2016
- Published by Springer Nature
- p. 47-67
Anatomy and Function of the Direct and Indirect Striatal Pathways
- 5 November 2016
- Published by Springer Nature
- p. 47-67
Anatomy and Function of the Direct and Indirect Striatal Pathways
- 1 September 2015
- Published by Elsevier in Neuroscience
- Vol. 303, 586-594
Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice
- 1 September 2015
- Published by Elsevier in Neuroscience
- Vol. 303, 586-594
Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice
- 1 September 2014
- Published by Elsevier in Neuroscience
- Vol. 275, 238-247
Loss of glutamic acid decarboxylase (Gad67) in Gpr88-expressing neurons induces learning and social behavior deficits in mice
- 1 September 2014
- Published by Elsevier in Neuroscience
- Vol. 275, 238-247
Loss of glutamic acid decarboxylase (Gad67) in Gpr88-expressing neurons induces learning and social behavior deficits in mice
- 1 September 2013
- Published by Elsevier in Brain Research
- Vol. 1531, 37-47
Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s disease
- 1 September 2013
- Published by Elsevier in Brain Research
- Vol. 1531, 37-47
Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s disease
- 1 November 2010
- Published by Elsevier in Experimental Neurology
- Vol. 226 (1) , 207-217
Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease
- 1 November 2010
- Published by Elsevier in Experimental Neurology
- Vol. 226 (1) , 207-217
Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease
- 1 June 2010
- Published by Elsevier in Neuroscience
- Vol. 168 (1) , 74-81
Effects of age on axon terminals forming axosomatic and axodendritic inhibitory synapses in prefrontal cortex
- 1 June 2010
- Published by Elsevier in Neuroscience
- Vol. 168 (1) , 74-81
Effects of age on axon terminals forming axosomatic and axodendritic inhibitory synapses in prefrontal cortex